---
title: "Silexion Therapeutics Corp (SLXN.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/SLXN.US.md"
symbol: "SLXN.US"
name: "Silexion Therapeutics Corp"
industry: "生物技术"
---

# Silexion Therapeutics Corp (SLXN.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [ilexion.com](https://ilexion.com) |

## Company Profile

Silexion Therapeutics Corp 是一家生物制药公司，专注于发现和开发基于 RNA 干扰（RNAi）的癌症药物和递送系统，以治疗恶性实体肿瘤。该公司通过其专有的 LODER 递送平台进行实体肿瘤的治疗。其产品包括已完成临床前研究和开放标签 I 期临床试验的 SiG12D-LODER，用于治疗胰腺癌；正在进行临床前研究的前列腺-LODER，用于治疗前列腺癌；以及正在进行临床前研究的 GBM-LODER，旨在靶向多形性胶质母细胞瘤，这是一种恶性的原发性脑肿瘤。Silexion Therapeutics Corp 与 Evonik Corporation 合作开发先进的 siRN...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.58 | 152/606 | - | - | - |
| PB | 0.77 | 65/606 | 1.09 | 0.94 | 0.74 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-12-16T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 50% |
| Overweight | 1 | 50% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 17.55 |
| Highest Target | 75.00 |
| Lowest Target | 75.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/SLXN.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/SLXN.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/SLXN.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.